| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.896 | 0.003 | 0.961 | Vasodilator, peripheral | 0.961 0.002 DBMET02588 | DBMET02588 | |
| 0.882 | 0.004 | 0.925 | Platelet antagonist | 0.925 0.003 DBMET02588 | DBMET02588 | |
| 0.82 | 0.004 | 0.898 | Antithrombotic | 0.898 0.003 DBMET02588 | DBMET02588 | |
| 0.743 | 0.001 | 0.897 | Prostaglandin F2 alpha antagonist | 0.897 0 DBMET02588 | DBMET02588 | |
| 0.733 | 0.002 | 0.783 | Prostaglandin EP2 antagonist | 0.783 0.001 DBMET02588 | DBMET02588 | |
| 0.673 | 0.005 | 0.728 | Vasodilator | 0.728 0.004 DBMET02588 | DBMET02588 | |
| 0.668 | 0.005 | 0.809 | Platelet aggregation inhibitor | 0.809 0.004 DBMET02588 | DBMET02588 | |
| 0.664 | 0.008 | 0.709 | Spasmolytic | 0.709 0.005 DBMET02588 | DBMET02588 | |
| 0.628 | 0.003 | 0.885 | Prostaglandin antagonist | 0.885 0.002 DBMET02588 | DBMET02588 | |
| 0.6 | 0.007 | 0.72 | Hypolipemic | 0.72 0.004 DBMET02588 | DBMET02588 | |
| 0.569 | 0.003 | 0.607 | Gastric antisecretory | 0.607 0.003 DBMET02588 | DBMET02588 | |
| 0.557 | 0.002 | 0.842 | Prostaglandin EP4 antagonist | 0.842 0.001 DBMET02588 | DBMET02588 | |
| 0.55 | 0.003 | 0.713 | Prostaglandin E2 antagonist | 0.713 0.002 DBMET02588 | DBMET02588 | |
| 0.541 | 0.002 | 0.655 | Prostaglandin EP1 antagonist | 0.655 0.002 DBMET02588 | DBMET02588 | |
| 0.528 | 0.003 | 0.59 | Gastrin inhibitor | 0.59 0.003 DBMET02588 | DBMET02588 | |
| 0.524 | 0.041 | 0.595 | Transcription factor NF kappa B inhibitor | 0.595 0.032 DBMET02588 | DBMET02588 | |
| 0.511 | 0.03 | 0.566 | Immunosuppressant | 0.566 0.018 DBMET02588 | DBMET02588 | |
| 0.477 | 0.002 | 0.56 | Prostaglandin EP3 antagonist | 0.56 0.001 DBMET02588 | DBMET02588 | |
| 0.464 | 0.001 | 0.611 | Prostaglandin D2 agonist | 0.611 0.001 DBMET02588 | DBMET02588 | |
| 0.453 | 0.002 | 0.824 | Thromboxane antagonist | 0.824 0.001 DBMET02588 | DBMET02588 | |
| 0.447 | 0.001 | 0.821 | Prostaglandin agonist | 0.821 0 DBMET02588 | DBMET02588 | |
| 0.448 | 0.005 | 0.545 | Hemostatic | 0.545 0.004 DBMET02588 | DBMET02588 | |
| 0.431 | 0.002 | 0.835 | Thromboxane A2 antagonist | 0.835 0.001 DBMET02588 | DBMET02588 | |
| 0.432 | 0.009 | 0.506 | Platelet adhesion inhibitor | 0.506 0.005 DBMET02588 | DBMET02588 | |
| 0.411 | 0.001 | 0.83 | Prostaglandin E2 agonist | 0.83 0 DBMET02588 | DBMET02588 | |
| 0.415 | 0.009 | 0.482 | Bone formation stimulant | 0.482 0.006 DBMET02588 | DBMET02588 | |
| 0.375 | 0.026 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.355 0.037 DBMET02588 | ||
| 0.398 | 0.05 | 0.404 | Immunostimulant | 0.404 0.048 DBMET02588 | DBMET02588 | |
| 0.437 | 0.117 | 0.602 | Antiinflammatory | 0.602 0.053 DBMET02588 | DBMET02588 | |
| 0.332 | 0.022 | 0.416 | Hepatoprotectant | 0.416 0.012 DBMET02588 | DBMET02588 | |
| 0.406 | 0.111 | 0.471 | Apoptosis agonist | 0.471 0.083 DBMET02588 | DBMET02588 | |
| 0.331 | 0.038 | 0.394 | Angiogenesis stimulant | 0.394 0.023 DBMET02588 | DBMET02588 | |
| 0.288 | 0.002 | 0.468 | Prostacyclin agonist | 0.468 0.001 DBMET02588 | DBMET02588 | |
| 0.322 | 0.059 | 0.408 | Interleukin 2 agonist | 0.408 0.025 DBMET02588 | DBMET02588 | |
| 0.258 | 0.004 | 0.288 | Adenylate cyclase stimulant | 0.288 0.003 DBMET02588 | DBMET02588 | |
| 0.321 | 0.072 | 0.422 | Apoptosis antagonist | 0.422 0.033 DBMET02588 | DBMET02588 | |
| 0.319 | 0.07 | 0.406 | Caspase 3 stimulant | 0.406 0.043 DBMET02588 | DBMET02588 | |
| 0.258 | 0.017 | 0.425 | Cholesterol synthesis inhibitor | 0.425 0.004 DBMET02588 | DBMET02588 | |
| 0.23 | 0.016 | 0.275 | Neurotrophic factor | 0.275 0.009 DBMET02588 | DBMET02588 | |
| 0.282 | 0.069 | 0.35 | Antioxidant | 0.35 0.046 DBMET02588 | DBMET02588 | |
| 0.227 | 0.015 | 0.279 | Bronchodilator | 0.279 0.01 DBMET02588 | DBMET02588 | |
| 0.255 | 0.047 | 0.255 | Peptidyltransferase inhibitor | 0.231 0.066 DBMET02588 | ||
| 0.27 | 0.065 | 0.32 | Interleukin agonist | 0.32 0.039 DBMET02588 | DBMET02588 | |
| 0.203 | 0 | 0.456 | Prostaglandin F2 alpha agonist | 0.456 0 DBMET02588 | DBMET02588 | |
| 0.253 | 0.051 | 0.326 | Nitric oxide antagonist | 0.326 0.036 DBMET02588 | DBMET02588 | |
| 0.27 | 0.08 | 0.27 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 DBMET02588 | ||
| 0.313 | 0.126 | 0.313 | Antibacterial | 0.311 0.127 DBMET02588 | ||
| 0.284 | 0.102 | 0.534 | Cholesterol antagonist | 0.534 0.027 DBMET02588 | DBMET02588 | |
| 0.216 | 0.036 | 0.347 | Interferon gamma antagonist | 0.347 0.014 DBMET02588 | DBMET02588 | |
| 0.189 | 0.012 | 0.189 | Sphingomyelinase inhibitor | |||
| 0.199 | 0.028 | 0.249 | DNA polymerase I inhibitor | 0.249 0.017 DBMET02588 | DBMET02588 | |
| 0.207 | 0.038 | 0.406 | Melanin inhibitor | 0.406 0.011 DBMET02588 | DBMET02588 | |
| 0.161 | 0.002 | 0.588 | Prostaglandin EP2 agonist | 0.588 0 DBMET02588 | DBMET02588 | |
| 0.16 | 0.002 | 0.521 | Prostaglandin EP4 agonist | 0.521 0 DBMET02588 | DBMET02588 | |
| 0.324 | 0.169 | 0.524 | Caspase 9 stimulant | 0.524 0.051 DBMET02588 | DBMET02588 | |
| 0.153 | 0.001 | 0.741 | Thromboxane agonist | 0.741 0 DBMET02588 | DBMET02588 | |
| 0.193 | 0.044 | 0.202 | ATPase inhibitor | 0.202 0.035 DBMET02588 | DBMET02588 | |
| 0.204 | 0.057 | 0.288 | Growth hormone agonist | 0.288 0.035 DBMET02588 | DBMET02588 | |
| 0.256 | 0.11 | 0.313 | Immunomodulator | 0.313 0.075 DBMET02588 | DBMET02588 | |
| 0.143 | 0.004 | 0.368 | Prostacyclin antagonist | 0.368 0.003 DBMET02588 | DBMET02588 | |
| 0.184 | 0.046 | 0.321 | Hexokinase inhibitor | 0.321 0.009 DBMET02588 | DBMET02588 | |
| 0.157 | 0.032 | 0.158 | Vanilloid 1 agonist | 0.158 0.031 DBMET02588 | DBMET02588 | |
| 0.128 | 0.015 | 0.128 | Vanilloid agonist | 0.124 0.016 DBMET02588 | ||
| 0.117 | 0.004 | 0.126 | Nitric oxide donor | 0.126 0.004 DBMET02588 | DBMET02588 | |
| 0.149 | 0.038 | 0.229 | Microtubule formation inhibitor | 0.229 0.014 DBMET02588 | DBMET02588 | |
| 0.176 | 0.066 | 0.319 | Phospholipase C inhibitor | 0.319 0.017 DBMET02588 | DBMET02588 | |
| 0.115 | 0.008 | 0.322 | Leukotriene B4 antagonist | 0.322 0.003 DBMET02588 | DBMET02588 | |
| 0.115 | 0.016 | 0.339 | Leukotriene antagonist | 0.339 0.003 DBMET02588 | DBMET02588 | |
| 0.131 | 0.034 | 0.131 | Electron transport complex I inhibitor | 0.108 0.066 DBMET02588 | ||
| 0.117 | 0.022 | 0.127 | ATPase (Vacuolar H+) inhibitor | 0.127 0.015 DBMET02588 | DBMET02588 | |
| 0.172 | 0.088 | 0.22 | P-glycoprotein inhibitor | 0.22 0.053 DBMET02588 | DBMET02588 | |
| 0.087 | 0.003 | 0.103 | HMG CoA reductase inhibitor | 0.103 0.002 DBMET02588 | DBMET02588 | |
| 0.18 | 0.096 | 0.264 | Insulin sensitizer | 0.264 0.027 DBMET02588 | DBMET02588 | |
| 0.142 | 0.058 | 0.149 | Toll-Like receptor 2 antagonist | 0.149 0.053 DBMET02588 | DBMET02588 | |
| 0.207 | 0.124 | 0.207 | Transcription factor STAT3 inhibitor | 0.195 0.14 DBMET02588 | ||
| 0.086 | 0.009 | 0.224 | Thromboxane synthase inhibitor | 0.224 0.003 DBMET02588 | DBMET02588 | |
| 0.14 | 0.065 | 0.171 | Farnesoid X receptor antagonist | 0.171 0.034 DBMET02588 | DBMET02588 | |
| 0.111 | 0.038 | 0.144 | ABCA1 expression enhancer | 0.144 0.019 DBMET02588 | DBMET02588 | |
| 0.116 | 0.043 | 0.151 | Anabolic | 0.151 0.017 DBMET02588 | DBMET02588 | |
| 0.146 | 0.076 | 0.242 | NOS3 expression enhancer | 0.242 0.028 DBMET02588 | DBMET02588 | |
| 0.142 | 0.074 | 0.283 | Protein kinase stimulant | 0.283 0.019 DBMET02588 | DBMET02588 | |
| 0.128 | 0.061 | 0.193 | Adenylate cyclase inhibitor | 0.193 0.027 DBMET02588 | DBMET02588 | |
| 0.076 | 0.011 | 0.076 | Vanilloid 2 antagonist | 0.062 0.02 DBMET02588 | ||
| 0.114 | 0.05 | 0.144 | Toll-Like receptor 4 antagonist | 0.144 0.024 DBMET02588 | DBMET02588 | |
| 0.119 | 0.06 | 0.159 | TRPA1 agonist | 0.159 0.025 DBMET02588 | DBMET02588 | |
| 0.078 | 0.023 | 0.078 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 DBMET02588 | ||
| 0.097 | 0.042 | 0.106 | Transcription factor NF kappa B stimulant | 0.106 0.034 DBMET02588 | DBMET02588 | |
| 0.079 | 0.026 | 0.079 | Neuraminidase inhibitor | 0.073 0.031 DBMET02588 | ||
| 0.072 | 0.022 | 0.077 | Sphingosine kinase inhibitor | 0.077 0.018 DBMET02588 | DBMET02588 | |
| 0.097 | 0.047 | 0.136 | Antineoplastic antibiotic | 0.136 0.034 DBMET02588 | DBMET02588 | |
| 0.076 | 0.029 | 0.076 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET02588 | ||
| 0.046 | 0.002 | 0.22 | Thromboxane A2 agonist | 0.22 0 DBMET02588 | DBMET02588 | |
| 0.252 | 0.211 | 0.485 | Cyclophilin D inhibitor | 0.485 0.055 DBMET02588 | DBMET02588 | |
| 0.08 | 0.041 | 0.081 | Vanilloid 4 agonist | 0.081 0.039 DBMET02588 | DBMET02588 | |
| 0.176 | 0.138 | 0.312 | Hypoglycemic | 0.312 0.049 DBMET02588 | DBMET02588 | |
| 0.04 | 0.005 | 0.066 | Leukotriene B4 receptor 2 antagonist | 0.066 0.004 DBMET02588 | DBMET02588 | |
| 0.085 | 0.055 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.04 | 0.011 | 0.079 | Leukotriene B4 receptor 1 antagonist | 0.079 0.004 DBMET02588 | DBMET02588 | |
| 0.06 | 0.031 | 0.075 | Protein 50S ribosomal subunit inhibitor | 0.075 0.022 DBMET02588 | DBMET02588 | |
| 0.047 | 0.02 | 0.047 | Sphingosine kinase 1 inhibitor | 0.045 0.022 DBMET02588 | ||
| 0.03 | 0.004 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 DBMET02588 | ||
| 0.049 | 0.023 | 0.056 | Parathyroid hormone antagonist | 0.056 0.015 DBMET02588 | DBMET02588 | |
| 0.032 | 0.009 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET02588 | ||
| 0.116 | 0.093 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.048 | 0.027 | 0.048 | Neuraminidase (Influenza A) inhibitor | |||
| 0.083 | 0.064 | 0.123 | Ornithine decarboxylase inhibitor | 0.123 0.024 DBMET02588 | DBMET02588 | |
| 0.023 | 0.005 | 0.053 | Vitamin D receptor agonist | 0.053 0.002 DBMET02588 | DBMET02588 | |
| 0.125 | 0.108 | 0.182 | Phospholipase A2 inhibitor | 0.182 0.053 DBMET02588 | DBMET02588 | |
| 0.026 | 0.009 | 0.031 | Vitamin D receptor antagonist | 0.031 0.007 DBMET02588 | DBMET02588 | |
| 0.069 | 0.054 | 0.083 | Aminopeptidase I inhibitor | 0.083 0.039 DBMET02588 | DBMET02588 | |
| 0.028 | 0.015 | 0.089 | Prostaglandin H2 antagonist | 0.089 0.002 DBMET02588 | DBMET02588 | |
| 0.071 | 0.059 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 DBMET02588 | DBMET02588 | |
| 0.034 | 0.024 | 0.037 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.016 DBMET02588 | DBMET02588 | |
| 0.063 | 0.055 | 0.158 | Peroxisome proliferator-activated receptor gamma agonist | 0.158 0.011 DBMET02588 | DBMET02588 | |
| 0.059 | 0.05 | 0.073 | Selectin antagonist | 0.073 0.04 DBMET02588 | DBMET02588 | |
| 0.023 | 0.015 | 0.026 | CYP24 inhibitor | 0.026 0.013 DBMET02588 | DBMET02588 | |
| 0.043 | 0.037 | 0.053 | Microtubule stabilization | 0.053 0.024 DBMET02588 | DBMET02588 | |
| 0.151 | 0.144 | 0.18 | Free radical scavenger | 0.18 0.115 DBMET02588 | DBMET02588 | |
| 0.03 | 0.024 | 0.052 | Squalene synthetase inhibitor | 0.052 0.014 DBMET02588 | DBMET02588 | |
| 0.037 | 0.032 | 0.046 | Membrane dipeptidase inhibitor | 0.046 0.019 DBMET02588 | DBMET02588 | |
| 0.021 | 0.017 | 0.131 | Prostaglandin D2 antagonist | 0.131 0.004 DBMET02588 | DBMET02588 | |
| 0.01 | 0.009 | 0.015 | Calcineurin inhibitor | 0.015 0.005 DBMET02588 | DBMET02588 | |
| 0.115 | 0.117 | 0.133 | Thrombolytic | 0.133 0.096 DBMET02588 | DBMET02588 | |
| 0.068 | 0.07 | 0.089 | Keratolytic | 0.089 0.039 DBMET02588 | DBMET02588 | |
| 0.05 | 0.068 | 0.062 | Lipocortins synthesis agonist | 0.062 0.032 DBMET02588 | DBMET02588 | |
| 0.039 | 0.058 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET02588 | DBMET02588 | |
| 0.084 | 0.104 | 0.165 | Adenylate kinase inhibitor | 0.165 0.022 DBMET02588 | DBMET02588 | |
| 0.121 | 0.143 | 0.169 | Antipruritic | 0.169 0.074 DBMET02588 | DBMET02588 | |
| 0.123 | 0.146 | 0.151 | Interleukin antagonist | 0.151 0.117 DBMET02588 | DBMET02588 | |
| 0.073 | 0.098 | 0.079 | Hematopoietic | 0.079 0.075 DBMET02588 | DBMET02588 | |
| 0.049 | 0.074 | 0.119 | Leukotriene synthesis inhibitor | 0.119 0.017 DBMET02588 | DBMET02588 | |
| 0.12 | 0.147 | 0.163 | Interleukin 6 antagonist | 0.163 0.071 DBMET02588 | DBMET02588 | |
| 0.084 | 0.112 | 0.1 | Alkylator | 0.1 0.089 DBMET02588 | DBMET02588 | |
| 0.069 | 0.102 | 0.114 | Prolactin inhibitor | 0.114 0.042 DBMET02588 | DBMET02588 | |
| 0.065 | 0.101 | 0.082 | Aminopeptidase B inhibitor | 0.082 0.079 DBMET02588 | DBMET02588 | |
| 0.012 | 0.052 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET02588 | DBMET02588 | |
| 0.062 | 0.107 | 0.133 | Monophenol monooxygenase inhibitor | 0.133 0.054 DBMET02588 | DBMET02588 | |
| 0.023 | 0.069 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET02588 | DBMET02588 | |
| 0.103 | 0.154 | 0.209 | Arachidonic acid antagonist | 0.209 0.025 DBMET02588 | DBMET02588 | |
| 0.017 | 0.069 | 0.028 | Retinoid X gamma receptor antagonist | 0.028 0.017 DBMET02588 | DBMET02588 | |
| 0.081 | 0.135 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 DBMET02588 | DBMET02588 | |
| 0.009 | 0.066 | 0.02 | Retinoid X beta receptor agonist | 0.02 0.016 DBMET02588 | DBMET02588 | |
| 0.159 | 0.229 | 0.202 | Tyrosine 3 hydroxylase inhibitor | 0.202 0.133 DBMET02588 | DBMET02588 | |
| 0.07 | 0.142 | 0.122 | Mucolytic | 0.122 0.052 DBMET02588 | DBMET02588 | |
| 0.039 | 0.118 | 0.063 | Elastase 1 inhibitor | 0.063 0.057 DBMET02588 | DBMET02588 | |
| 0.018 | 0.097 | 0.095 | Peroxisome proliferator-activated receptor alpha agonist | 0.095 0.013 DBMET02588 | DBMET02588 | |
| 0.06 | 0.139 | 0.171 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.171 0.021 DBMET02588 | DBMET02588 | |
| 0.045 | 0.133 | 0.071 | CDC25A inhibitor | 0.071 0.055 DBMET02588 | DBMET02588 | |
| 0.057 | 0.145 | 0.114 | Expectorant | 0.114 0.055 DBMET02588 | DBMET02588 | |
| 0.107 | 0.197 | 0.3 | Non-steroidal antiinflammatory agent | 0.3 0.028 DBMET02588 | DBMET02588 | |
| 0.009 | 0.102 | 0.023 | Leukotriene D4 antagonist | 0.023 0.021 DBMET02588 | DBMET02588 | |
| 0.071 | 0.167 | 0.111 | Folate antagonist | 0.111 0.048 DBMET02588 | DBMET02588 | |
| 0.065 | 0.165 | 0.081 | T cell inhibitor | 0.081 0.063 DBMET02588 | DBMET02588 | |
| 0.041 | 0.143 | 0.066 | Leukotriene C antagonist | 0.066 0.019 DBMET02588 | DBMET02588 | |
| 0.106 | 0.21 | 0.176 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET02588 | DBMET02588 | |
| 0.049 | 0.156 | 0.1 | Protein-tyrosine phosphatase 1B inhibitor | 0.1 0.078 DBMET02588 | DBMET02588 | |
| 0.025 | 0.147 | 0.042 | Leukotriene C4 antagonist | 0.042 0.019 DBMET02588 | DBMET02588 | |
| 0.024 | 0.152 | 0.046 | Kainate receptor agonist | 0.046 0.019 DBMET02588 | DBMET02588 | |
| 0.069 | 0.198 | 0.099 | Cell adhesion inhibitor | 0.099 0.091 DBMET02588 | DBMET02588 | |
| 0.038 | 0.175 | 0.094 | Glutamate dehydrogenase inhibitor | 0.094 0.034 DBMET02588 | DBMET02588 | |
| 0.022 | 0.166 | 0.141 | Phosphofructokinase-1 inhibitor | 0.141 0.02 DBMET02588 | DBMET02588 | |
| 0.01 | 0.154 | 0.047 | Fumarate hydratase inhibitor | 0.047 0.015 DBMET02588 | DBMET02588 | |
| 0.069 | 0.214 | 0.13 | Protein-tyrosine phosphatase inhibitor | 0.13 0.101 DBMET02588 | DBMET02588 | |
| 0.023 | 0.189 | 0.072 | Glucose-6-phosphate isomerase inhibitor | 0.072 0.011 DBMET02588 | DBMET02588 | |
| 0.136 | 0.303 | 0.278 | Toll-Like receptor agonist | 0.278 0.125 DBMET02588 | DBMET02588 | |
| 0.019 | 0.205 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.031 DBMET02588 | DBMET02588 | |
| 0.14 | 0.332 | 0.187 | 5 Hydroxytryptamine uptake stimulant | 0.187 0.181 DBMET02588 | DBMET02588 | |
| 0.128 | 0.321 | 0.266 | Toll-Like receptor 7 agonist | 0.266 0.134 DBMET02588 | DBMET02588 | |
| 0.024 | 0.219 | 0.075 | Glutamate decarboxylase inhibitor | 0.075 0.049 DBMET02588 | DBMET02588 | |
| 0.017 | 0.226 | 0.062 | Biliverdin reductase inhibitor | 0.062 0.039 DBMET02588 | DBMET02588 | |
| 0.028 | 0.243 | 0.073 | GABA aminotransferase inhibitor | 0.073 0.057 DBMET02588 | DBMET02588 | |
| 0.009 | 0.225 | 0.041 | ATP citrate lysase inhibitor | 0.041 0.012 DBMET02588 | DBMET02588 | |
| 0.092 | 0.311 | 0.222 | Lipoxygenase inhibitor | 0.222 0.12 DBMET02588 | DBMET02588 | |
| 0.123 | 0.35 | 0.25 | Histamine release inhibitor | 0.25 0.155 DBMET02588 | DBMET02588 | |
| 0.017 | 0.258 | 0.091 | Aconitate hydratase inhibitor | 0.091 0.01 DBMET02588 | DBMET02588 | |
| 0.094 | 0.34 | 0.17 | DNA synthesis inhibitor | 0.17 0.168 DBMET02588 | DBMET02588 | |
| 0.036 | 0.306 | 0.093 | Bile acid receptor antagonist | 0.093 0.066 DBMET02588 | DBMET02588 | |
| 0.017 | 0.296 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.035 DBMET02588 | DBMET02588 | |
| 0.03 | 0.311 | 0.072 | Glycine receptor agonist | 0.072 0.051 DBMET02588 | DBMET02588 | |
| 0.031 | 0.313 | 0.143 | GABA C receptor agonist | 0.143 0.037 DBMET02588 | DBMET02588 | |
| 0.097 | 0.38 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 DBMET02588 | DBMET02588 | |
| 0.037 | 0.323 | 0.123 | Amylase inhibitor | 0.123 0.079 DBMET02588 | DBMET02588 | |
| 0.032 | 0.357 | 0.101 | Triose-phosphate isomerase inhibitor | 0.101 0.046 DBMET02588 | DBMET02588 | |
| 0.011 | 0.344 | 0.066 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.037 DBMET02588 | DBMET02588 | |
| 0.025 | 0.363 | 0.115 | Cystathionine beta-synthase inhibitor | 0.115 0.062 DBMET02588 | DBMET02588 | |
| 0.046 | 0.436 | 0.148 | Succinate dehydrogenase inhibitor | 0.148 0.115 DBMET02588 | DBMET02588 | |
| 0.024 | 0.443 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.056 DBMET02588 | DBMET02588 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |